This inventor holds 1 USPTO granted patent. Top assignee: Shanghai Genechem Co., Ltd.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Dalong Lv: Innovator in Tumor Treatment
Introduction
Dalong Lv is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of genetics and oncology through his innovative research. His work focuses on the human ZFX gene and its applications in tumor treatment and diagnosis.
Latest Patents
Dalong Lv holds a patent titled "Uses of the human ZFX gene and drugs associated with same." This invention discloses various uses of the human ZFX gene, particularly in tumor treatment and diagnosis. The patent also details the development of small interfering RNA (siRNA) and nucleic acids that can specifically inhibit the expression of the human ZFX gene. The lentivirus encoding the siRNA can efficiently infect target cells, inhibit ZFX expression, and promote tumor apoptosis, making it a significant advancement in cancer therapy.
Career Highlights
Dalong Lv is associated with Shanghai Genechem Co., Ltd., where he continues to advance his research in genetic applications. His work has garnered attention for its potential impact on cancer treatment and drug preparation.
Collaborations
Dalong has collaborated with notable colleagues, including Yueqiong Cao and Yangsheng Jin, to further enhance the research and development of innovative solutions in the field of oncology.
Conclusion
Dalong Lv's contributions to the understanding and treatment of tumors through his research on the human ZFX gene highlight his role as a key innovator in the field. His work promises to pave the way for new therapeutic strategies in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile